Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.27 - $1.75 $20,937 - $28,850
16,486 Added 40.69%
56,998 $90,000
Q1 2024

May 14, 2024

BUY
$1.21 - $1.75 $17,306 - $25,030
14,303 Added 54.57%
40,512 $58,000
Q4 2023

Feb 13, 2024

SELL
$0.89 - $1.41 $21,771 - $34,491
-24,462 Reduced 48.28%
26,209 $35,000
Q3 2023

Nov 15, 2023

BUY
$1.08 - $1.85 $54,724 - $93,741
50,671 New
50,671 $71,000
Q2 2023

Aug 11, 2023

SELL
$0.96 - $1.4 $41,504 - $60,527
-43,234 Closed
0 $0
Q4 2022

Aug 11, 2023

BUY
$1.27 - $2.26 $27,011 - $48,067
21,269 Added 96.83%
43,234 $65,000
Q4 2022

Feb 13, 2023

BUY
$1.27 - $2.26 $27,011 - $48,067
21,269 Added 96.83%
43,234 $65,000
Q3 2022

Aug 11, 2023

SELL
$1.41 - $2.79 $32,599 - $64,504
-23,120 Reduced 51.28%
21,965 $46,000
Q3 2022

Nov 03, 2022

BUY
$1.41 - $2.79 $30,970 - $61,282
21,965 New
21,965 $47,000
Q2 2022

Aug 15, 2022

SELL
$1.15 - $2.53 $51,847 - $114,065
-45,085 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$1.91 - $3.98 $3,535 - $7,366
1,851 Added 4.28%
45,085 $95,000
Q1 2022

May 20, 2022

SELL
$1.91 - $3.98 $17,291 - $36,030
-9,053 Reduced 16.72%
45,085 $95,000
Q4 2021

Feb 16, 2022

BUY
$3.53 - $5.5 $3,886 - $6,055
1,101 Added 2.08%
54,138 $201,000
Q3 2021

Nov 12, 2021

SELL
$4.99 - $6.55 $14,820 - $19,453
-2,970 Reduced 5.3%
53,037 $265,000
Q2 2021

Aug 12, 2021

BUY
$6.24 - $8.22 $83,204 - $109,605
13,334 Added 31.25%
56,007 $365,000
Q1 2021

May 03, 2021

BUY
$6.74 - $10.95 $6,955 - $11,300
1,032 Added 2.48%
42,673 $294,000
Q4 2020

Feb 12, 2021

SELL
$3.75 - $10.56 $4,297 - $12,101
-1,146 Reduced 2.68%
41,641 $425,000
Q2 2020

Aug 10, 2020

SELL
$2.16 - $5.46 $18,671 - $47,196
-8,644 Reduced 16.81%
42,787 $209,000
Q1 2020

May 15, 2020

BUY
$1.46 - $7.19 $75,089 - $369,788
51,431 New
51,431 $175,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $179M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.